Methazolamide, Blood

Purpose

Therapeutic Drug Monitoring

Method(s)

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

Suggested CPT Code(s)

80375

New York State Approval Status

Approved

Turnaround Time

5 days

Test Includes


1	Methazolamide	Neptazane®	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	mcg/mL	0.5	Carbonic Anhydrase Inhibitor

Specimen Type

Blood

Requested Volume

1 mL

Minimum Volume

0.2 mL

Special Handling

None

Specimen Container

Lavender top tube (EDTA)

Additional Collection Instructions

Transport Temperature

Refrigerated

Light Protection

Not Required

Rejection Criteria

None

Rejection criteria pertain to clinical specimen submissions only.

Stability

Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 30 day(s)


1	Methazolamide	Neptazane®	High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)	mcg/mL	0.5	Carbonic Anhydrase Inhibitor

Example Report (Negative)

Example Report (Positive)

Interface Map

2863B Methazolamide, Blood - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Methazolamide	mcg/mL	METHAZOLAM

LOINC^® Information

2863B Methazolamide, Blood - Current Version
Analyte	Units	Analyte Mapping Code	LOINC®
Methazolamide	mcg/mL	METHAZOLAM


Some LOINC^® codes may not have been assigned or are not available. The LOINC^® codes are copyright © 1995-2017, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. All rights reserved. Additional information can be found at LOINC.org.

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.